Search Results - "Peterson, Patrick M"

Health and resource burden of a cancer diagnosis on the caregiver: an analysis of administrative claims data by Hess, Lisa M, Wong-Jacobson, Siew Hoong, Peterson, Patrick M

“…Purpose Cancer diagnosis is known to affect the family; however, administrative claims data are not commonly used to evaluate the broader impact of cancer…”
Get full text

TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR -Mutant Non-Small Cell Lung Cancer by Le, Xiuning, Molife, Cliff, Leusch, Mark S, Rizzo, Maria Teresa, Peterson, Patrick M, Caria, Nicola, Chen, Yongmei, Gugel, Elena Gonzalez, Visseren-Grul, Carla

“…co-mutations have shown association with poor prognosis in various solid tumors. For -mutated advanced non-small cell lung cancer (aNSCLC), conflicting results…”
Get full text

Phase III Study of Gemcitabine and Cisplatin With or Without Aprinocarsen, a Protein Kinase C-Alpha Antisense Oligonucleotide, in Patients With Advanced-Stage Non–Small-Cell Lung Cancer by PAZ-ARES, Luis, DOUILLARD, Jean-Yves, LAHN, Michael, GANDARA, David R, KORALEWSKI, Piotr, MANEGOLD, Christian, SMIT, Egbert F, REYES, José Miguel, CHANG, Gee-Chen, JOHN, William J, PETERSON, Patrick M, OBASAJU, Coleman K

“…To determine whether aprinocarsen, an antisense oligonucleotide directed against protein kinase C-alpha, when added to the chemotherapy regimen of gemcitabine…”
Get full text

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial by SCAGLIOTTI, Giorgio V, KORTSIK, Cornelius, NOVELLO, Silvia, BLATTER, Johannes, KAYITALIRE, Louis, CRINO, Lucio, PAZ-ARES, Luis, DARK, Graham G, PRICE, Allan, MANEGOLD, Christian, ROSELL, Rafael, O'BRIEN, Mary, PETERSON, Patrick M, CASTELLANO, Daniel, SELVAGGI, Giovanni

“…Purpose: To determine efficacy and toxicity of two pemetrexed-based regimens in chemonaive patients with locally advanced or metastatic non–small cell lung…”
Get full text

Long-term safety of selpercatinib for Rearrenged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over time by Raez, Luis E, Massey, Ashish C, Barker, Scott S, Peterson, Patrick M, Liming, Katherine, Pennell, Nathan A

“…Selpercatinib is a selective RET inhibitor approved for treatment of RET-activated cancers. Adverse events (AEs) are manageable with dose modifications. This…”
Get full text

HSR24-128: Real-World Treatment Patterns and Effectiveness of Selpercatinib in Patients With Locally Advanced/Metastatic Non-Small Cell Lung Cancer in the US by Liao, Chi-Yin, Gonzalez-Ferrer, Carmen, Whipple, Samuel, Bhandari, Naleen Raj, Peterson, Patrick M, Barker, Scott S, Wang, Feng

Get more information

Prospective Evaluation of Doxorubicin Cardiotoxicity in Patients with Advanced Soft-tissue Sarcoma Treated in the ANNOUNCE Phase III Randomized Trial by Jones, Robin L, Wagner, Andrew J, Kawai, Akira, Tamura, Kazuo, Shahir, Ashwin, Van Tine, Brian A, Martín-Broto, Javier, Peterson, Patrick M, Wright, Jennifer, Tap, William D

“…Few prospective studies have assessed anthracycline-associated cardiotoxicity in patients with sarcoma. We evaluated cardiotoxicity in patients with…”
Get full text

Olaratumab-induced Biomarker Modulation in Sarcomas-Response by Martín-Broto, Javier, Peterson, Patrick M, Oakley, Gerard J, Ceccarelli, Matteo, Jones, Robin L

Get full text

Real-World Outcomes of Selective RET Inhibitor Selpercatinib in the United States: Descriptive, Retrospective Findings from Two Databases by Liao, Chi-Yin, Gonzalez-Ferrer, Carmen, Whipple, Samuel, Peterson, Patrick M., Barker, Scott S., Bhandari, Naleen Raj, Wang, Feng

“…Objectives: This study described real-world patient characteristics and outcomes among selpercatinib-treated patients in the United States, using the Flatiron…”
Get full text

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer by Gardner, Faithlore P, Wainberg, Zev A, Fountzilas, Christos, Bahary, Nathan, Womack, Mark S, Macarulla, Teresa, Garrido-Laguna, Ignacio, Peterson, Patrick M, Borazanci, Erkut, Johnson, Melissa, Ceccarelli, Matteo, Pelzer, Uwe

“…The efficacy and safety of olaratumab plus nabpaclitaxel and gemcitabine in treatment-naïve participants with metastatic pancreatic ductal adenocarcinoma was…”
Get full text

Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations by Winfree, Katherine B, Molife, Cliff, Peterson, Patrick M, Chen, Yongmei, Visseren-Grul, Carla M, Leusch, Mark S, Beyrer, Julie, Dimou, Anastasios

“…To estimate real-world (rw) outcomes for first-line therapy in patients with advanced EGF receptor ( )-mutated non-small-cell lung cancer (NSCLC), focusing on…”
Get full text

Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study by Ogata, Takatsugu, Narita, Yukiya, Wainberg, Zev A, Van Cutsem, Eric, Yamaguchi, Kensei, Piao, Yongzhe, Zhao, Yumin, Peterson, Patrick M, Wijayawardana, Sameera R, Abada, Paolo, Chatterjee, Anindya, Muro, Kei

“…Liver metastasis (LM) is reported in approximately 40% of patients with advanced/metastatic gastric/gastroesophageal junction adenocarcinoma (metastatic…”
Get full text

Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas by Attia, Steven, Villalobos, Victor, Hindi, Nadia, Wagner, Andrew J, Chmielowski, Bartosz, Oakley, 3rd, Gerard J, Peterson, Patrick M, Ceccarelli, Matteo, Jones, Robin L, Dickson, Mark A

“…Gemcitabine plus docetaxel is an effective treatment regimen for advanced soft tissue sarcomas (STSs). However, the prognosis for patients remains poor, and…”
Get full text

Exposure–response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcoma by Jones, Robin L., Mo, Gary, Baldwin, John R., Peterson, Patrick M., Ilaria, Robert L., Conti, Ilaria, Cronier, Damien M., Tap, William D.

“…Purpose Olaratumab is a recombinant human IgG1 monoclonal antibody against PGDFRα. Olaratumab plus doxorubicin improved survivalversus doxorubicin in an…”
Get full text

Long-term safety of selpercatinib for Rearranged during transfection ( RET) -activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over time by Raez, Luis E, Massey, Ashish C, Barker, Scott S, Peterson, Patrick M, Liming, Katherine, Pennell, Nathan A

Get full text

Simulating the response of multiple microphones to a single acoustic source in a reverberant room by PETERSON, P. M

“…A method is presented for simulating the impulse response between an acoustic source and multiple microphones in a reverberant room. The method is similar to…”
Get full text

Prospective evaluation of doxorubicin cardiotoxicity in advanced soft tissue sarcoma patients treated in the ANNOUNCE Phase 3 randomized trial by Jones, Robin L, Wagner, Andrew J, Kawai, Akira, Tamura, Kazuo, Shahir, Ashwin, Van Tine, Brian A, Broto, Javier Martin, Peterson, Patrick M, Wright, Jennifer, Tap, William D

Get full text

ITP53/I Co-Mutation Status Association with Clinical Outcomes in Patients with IEGFR/I-Mutant Non-Small Cell Lung Cancer by Le, Xiuning, Molife, Cliff, Leusch, Mark S, Rizzo, Maria Teresa, Peterson, Patrick M, Caria, Nicola, Chen, Yongmei, Gugel, Elena Gonzalez, Visseren-Grul, Carla

“…There is conflicting evidence on the impact of TP53 co-mutations on survival in patients with EGFR-mutated advanced non-small cell lung cancer (aNSCLC). This…”
Get full text

Geographic variation in the decline of stroke mortality in the United States by LANSKA, D. J, PETERSON, P. M

“…This study examines the geographic variation in the decline of stroke mortality rates in the United States. National Center for Health Statistics and Bureau of…”
Get full text

Effects of interstate migration on the geographic distribution of stroke mortality in the United States by LANSKA, D. J, PETERSON, P. M

“…This study examines the effects of lifetime net interstate migration on the geographic distribution of stroke mortality in the United States. National Center…”
Get full text